Author: John Pinching

New consultancy aims to deliver personalised senior expertise in healthcare communications

Results show disease control and tumour shrinkage with GNS561 and MEK inhibitor combination

Trial shows GRI-0621 improved lung function with signs of fibrosis resolution

MajesTEC-3 study supports teclistamab plus daratumumab SC as potential standard of care

Proof-of-concept phase begins with first patient enrolled